Welcome to LookChem.com Sign In|Join Free
  • or
4-(2-chloro-acetyl)-3,4-dihydro-1H-quinoxalin-2-one is a quinoxaline derivative with the molecular formula C10H8ClNO2. It is a chemical compound that has been studied for its various biological activities, including potential as an anticancer and antitumor agent. 4-(2-CHLORO-ACETYL)-3,4-DIHYDRO-1H-QUINOXALIN-2-ONE also exhibits antioxidant and antifungal properties, making it a versatile molecule of interest in research and pharmaceutical applications. Its structure contains a chloro-acetyl group, which can participate in reactions with other molecules, further expanding its utility in synthetic chemistry and drug discovery.

436088-67-4

Post Buying Request

436088-67-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

436088-67-4 Usage

Uses

Used in Pharmaceutical Applications:
4-(2-chloro-acetyl)-3,4-dihydro-1H-quinoxalin-2-one is used as a potential anticancer and antitumor agent due to its biological activities. It has been studied for its ability to target and inhibit the growth of cancer cells, making it a promising candidate for the development of new cancer therapies.
Used in Antioxidant Applications:
4-(2-CHLORO-ACETYL)-3,4-DIHYDRO-1H-QUINOXALIN-2-ONE is used as an antioxidant, which can help protect cells from damage caused by reactive oxygen species. Its antioxidant properties make it a valuable molecule for the development of treatments aimed at preventing or reducing oxidative stress-related diseases.
Used in Antifungal Applications:
4-(2-chloro-acetyl)-3,4-dihydro-1H-quinoxalin-2-one is used as an antifungal agent, exhibiting activity against various fungal species. Its antifungal properties can be utilized in the development of new treatments for fungal infections.
Used in Synthetic Chemistry:
Due to the presence of a chloro-acetyl group in its structure, 4-(2-chloro-acetyl)-3,4-dihydro-1H-quinoxalin-2-one is used in synthetic chemistry for its ability to participate in reactions with other molecules. This makes it a valuable building block for the synthesis of new compounds and drug candidates.
Used in Drug Discovery:
4-(2-CHLORO-ACETYL)-3,4-DIHYDRO-1H-QUINOXALIN-2-ONE's diverse biological activities and structural features make it a valuable asset in drug discovery. Researchers can use 4-(2-chloro-acetyl)-3,4-dihydro-1H-quinoxalin-2-one as a starting point for the development of new drugs targeting various diseases and conditions.

Check Digit Verification of cas no

The CAS Registry Mumber 436088-67-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,3,6,0,8 and 8 respectively; the second part has 2 digits, 6 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 436088-67:
(8*4)+(7*3)+(6*6)+(5*0)+(4*8)+(3*8)+(2*6)+(1*7)=164
164 % 10 = 4
So 436088-67-4 is a valid CAS Registry Number.
InChI:InChI=1/C10H9ClN2O2/c11-5-10(15)13-6-9(14)12-7-3-1-2-4-8(7)13/h1-4H,5-6H2,(H,12,14)

436088-67-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-(2-Chloro-acetyl)-3,4-dihydro-1H-quinoxalin-2-one

1.2 Other means of identification

Product number -
Other names 4-(2-chloroacetyl)-1,3-dihydroquinoxalin-2-one

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:436088-67-4 SDS

436088-67-4Relevant academic research and scientific papers

Design, synthesis and biological evaluation of quinoxaline compounds as anti-HIV agents targeting reverse transcriptase enzyme

Estrin, Darío,Fabian, Lucas,Gómez, Natalia,Moglioni, Albertina,Salvatori, Melina,Taverna Porro, Marisa,Turk, Gabriela

, (2019/12/30)

Infection by human immunodeficiency virus still represents a continuous serious concern and a global threat to human health. Due to appearance of multi-resistant virus strains and the serious adverse side effects of the antiretroviral therapy administered, there is an urgent need for the development of new treatment agents, more active, less toxic and with increased tolerability to mutations. Quinoxaline derivatives are an emergent class of heterocyclic compounds with a wide spectrum of biological activities and therapeutic applications. These types of compounds have also shown high potency in the inhibition of HIV reverse transcriptase and HIV replication in cell culture. For these reasons we propose, in this work, the design, synthesis and biological evaluation of quinoxaline derivatives targeting HIV reverse transcriptase enzyme. For this, we first carried out a structure-based development of target-specific compound virtual chemical library of quinoxaline derivatives. The rational construction of the virtual chemical library was based on previously assigned pharmacophore features. This library was processed by a virtual screening protocol employing molecular docking and 3D-QSAR. Twenty-five quinoxaline compounds were selected for synthesis in the basis of their docking and 3D-QSAR scores and chemical synthetic simplicity. They were evaluated as inhibitors of the recombinant wild-type reverse transcriptase enzyme. Finally, the anti-HIV activity and cytotoxicity of the synthesized quinoxaline compounds with highest reverse transcriptase inhibitory capabilities was evaluated. This simple screening strategy led to the discovery of two selective and potent quinoxaline reverse transcriptase inhibitors with high selectivity index.

Design, synthesis, molecular modeling and anti-hyperglycemic evaluation of novel quinoxaline derivatives as potential PPARγ and SUR agonists

Ibrahim, Mohammed K.,Eissa, Ibrahim H.,Abdallah, Abdallah E.,Metwaly, Ahmed M.,Radwan,ElSohly

, p. 1496 - 1513 (2017/02/10)

In our effort to develop potent anti-hyperglycemic agents with potential agonistic activities toward PPARγ and SUR, three novel series of quinoxaline derivatives bearing sulfonylurea or sulfonylthiourea moieties with different linkers were designed and synthesized. Some of the newly synthesized compounds were evaluated in vivo for their anti-hyperglycemic activities in STZ-induced hyperglycemic rats. Compounds 15a, 15e, 19band 24aexhibited the highest anti-hyperglycemic activities with % reduction in blood glucose level of (50.58, 43.84, 45.10 and 49.62, respectively). Additionally, eight compounds revealed potent anti-hyperglycemic activities were further evaluated in vitro for their PPARγ binding affinity and insulin-secreting ability as potential mechanisms for anti-hyperglycemic activity. Four compounds (15a, 15b, 15dand 15e) significantly bound to PPARγ with IC50values of 0.482, 0.491, 0.350 and 0.369 μM, respectively. Moreover, Compounds 15aand 15bhave demonstrated induction of insulin-secretion with EC50values of 0.92 and 0.98 μM, respectively. Furthermore, molecular docking and pharmacophore generation techniques were carried out to investigate binding patterns and fit values of the designed compounds with PPARγ and SUR, respectively.

Design, molecular docking and synthesis of some novel 4-acetyl-1-substituted-3,4-dihydroquinoxalin-2(1H)-one derivatives for anticonvulsant evaluation as AMPA-receptor antagonists

El-Helby, Abdel-Ghany A.,Ayyad, Rezk R. A.,El-Adl, Khaled,Sakr, Helmy,Abd-Elrahman, Ashraf A.,Eissa, Ibrahim H.,Elwan, Alaa

, p. 3030 - 3046 (2016/11/09)

A new series of 4-acetyl-1-substituted-3,4-dihydroquinoxalin-2(1H)-ones (2–13) were designed and synthesized in order to evaluate their AMPA-receptor antagonism as a potential mode of anticonvulsant activity. The structure of the synthesized compounds was

Synthesis of novel quinoxalinone derivatives by conventional and microwave methods and assessing their biological activity

Nasir, Waqar,Munawar, Munawar Ali,Ahmed, Ejaz,Sharif, Ahsan,Ahmed, Saeed,Ayub, Amjad,Khan, Misbahul Ain,Nasim, Faizul Hassan

scheme or table, p. 1605 - 1614 (2012/03/26)

In this study, twenty-one arylaminoquinoxalinone derivatives were synthesized and their antibacterial activities against Staphylococci aureus, Pseudomonas aureus, Escherichia coli, Bacillus subtilis, Salmonella typhi, and Shigella pneumoniae were evaluated relative to known antibiotics; augmentin, ampicillin, and chloramphenicol. The insecticidal activities of the prepared compounds were also investigated against Tribolium castaneum using permethrin as a standard insecticide. The derivatives were synthesized using both conventional and microwave techniques. Their structures were confirmed using spectral techniques and elemental analysis.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 436088-67-4